TESTIMONIALS
PATIENTS
PATIENT
USA
“They inserted the probe. They made a very small incision. Inserted the probe in my breast and froze it, and they walked me through every step of it. There was absolutely no pain at all..”
PATIENT
USA
“There’s no pain. I was apprehensive that morning but there was no reason to be. When we left there, there was no pain. I went home, we had a regular dinner and I’ve never looked back.”
PATIENT
Prague
“The procedure with ProSenseTM was very positive and I didn’t experience any pain. The cosmetic results are very good too. My skin doesn’t heal well after incisions, so I didn’t have to worry at all about bad scarring with this procedure. I have experienced fibroadenomas since I was 15 years old and was so pleased to have access to this new method to treat the problem.”
PATIENT
Prague
“I’m very pleased that I chose this procedure. I had expected to have some scarring, but the ProSenseTM procedure left none at all. I didn’t feel any discomfort or pain, and it was over very quickly. I’m really satisfied with the cosmetic and overall results.”
PHYSICIANS
JAN DANES MD
PROFESSOR OF RADIOLOGY
CHARLES UNIVERSITY IN PRAGUE
“When treating multiple fibroadenomas, the patient often requires multiple operations for excision and is left with multiple scars. ProSenseTM is a good alternative to regular surgery.”
“It’s a very compact system and simple to operate. We perform the procedure under local anesthesia and there’s no pain and no adverse reactions. It’s actually very similar to core-cut biopsy and lasts less than 30 minutes. All of our patients are very satisfied with it. They’re able to go home immediately after the procedure and don’t experience complications.”
“Over time, the destroyed fibroadenoma is completely replaced by natural fibrotic tissue.”
FRANCO ORSI MD
DIRECTOR INTERVENTIONAL ONCOLOGY
EUROPEAN INSTITUTE OF ONCOLOGY, MILAN
“I have been using cryoblation from IceCure for the last two years for treating patients with bone metastastic disease. One of the most important benefits coming from the experience in using cryoablation among the older ablation devices is that the treatment is completely unpainful. It means that usually the patient does not feel any pain during the treatment or afterwards.”
“Another important benefit compared to the older ablation devices is that we can really check the ablation area and the bouldering of the lesions because the iceball can be easily seen by using ultrasound and CT.”
“It also means that we can be very safe in treating lesions without harming any sensitive structures close to the target and we can also be very safe in covering the ablation area as we can see exactly where the boundary of the icecall is located. The ablation area is also good enough for treating our patients and our patients have benefits in terms of clinical control for pain. The results are very good and the technique is very easy.”
ANDREW KENLER, MD, FACS
“The recovery from an office-based cryoablation of a breast mass is immediate, and with this newer technology, only the tissue that needs to be destroyed or ablated is actually destroyed.”
“Cryoablation is a procedure that we know is safe, efficacious, cost effective and cosmetically superior to surgical removal. IceCure has improved upon the technology and developed a system optimized for breast fibroadenoma. My patients have been very happy with the short, painless procedure, and the ability to return to normal activity immediately.”
DAVID PAVLISTA MD PHD
ONCOGYNECOLOGICAL CENTER
CHARLES UNIVERSITY IN PRAGUE
“Many of our fibroadenoma patients have undergone open surgery to treat them, causing discomfort and large scars. With the ProSenseTM cryoablation procedure, patients are now very satisfied with the tiny incision that it makes. There is no bleeding, no hematoma, and no infection.”
“I’d emphasize that the ProSense procedure spares the ductal system, so that it’s a good solution for young women planning childbirth and breastfeeding.”
“The learning curve to treat with this cryoablation system is very short. Overall, it spares time for both patient and surgeon. It’s a truly excellent outpatient method.”
DEANNA J. ATTAI, MD, FACS
“It’s done in the office. It doesn’t take much time.”
“Women are looking for other options. They’re looking for a less invasive way to treat their fibroadenomas. They don’t want surgery and they don’t want to just watch and wait.”
“Why would you not want to take advantage of this and offer this to your patients? I think a lot of women have opted for observation because they didn’t want surgery, not realizing that now at least we have another option, so that the women don’t have to walk around with this lump in their breast that makes them anxious and concerned, but they also don’t have to go to the operating room.”
KAREN COLUMBUS, MD
CINCINNATI BREAST SURGEONS CRYOABLATION
“ProSenseTM cryoablation is a technique that actually freezes the lesion in the breast. We use local anesthetic to numb the skin to make a small nick. A probe is then inserted into the lesion under ultrasound guidance. The lesion is frozen within the breast. It’s a painless procedure because the ice ball that’s formed from the cryo procedure actually acts as an anesthetic in the breast. It takes about 20 minutes. The patients leave here without any pain, and can resume normal activities that day.”
“Patients have been really satisfied with this procedure. It’s an office-based procedure and avoids a trip to the operating room. It has great cosmetic results, with virtually non scarring, and no down time from surgery.”
PROF. OFER NATIV
HEAD OF THE UROLOGICAL DEPARTMENT AT THE
BNAI ZION MEDICAL CENTER AND ELISHA HOSPITAL
“We have been using IceCure’s ProSenseTM technology for a number of years now to freeze renal masses. We are highly satisfied with this liquid nitrogen-based technology, which incurs minimal complications, fast recovery, and excellent oncological outcomes. When renal mass treatment is without comorbidities, our patients undergoing the ProSense cryoablation procedure are able to resume regular activity and be discharged within just a few hours.”
JULIE SHULTZ MD – DIAGNOSTIC RADIOLOGY
SPECIALIST BREAST IMAGING AND
INTERVENTION – DETROIT, MI
“As a Breast Radiologist, I am always looking for the latest technology in my field so that I can better diagnose and treat breast disease. The ProSenseTM cryoablation system has been an incredibly valuable tool in the treatment of patients with benign fibroadenomas in our clinic. The device is very user-friendly for both the physician and technologist. Our patients have reported total satisfaction with the procedure and the results. With IceCure and the ProSenseTM system, we are happy to be able to provide a fast, safe, and minimally-invasive alternative to open surgical resection.”
keynote PRESENTATIONS FROM leading EXPERTS
Dr. Richard E. Fine
Director of Education and Research, West Cancer Center’s Comprehensive Breast Center, USA, TN and ICE3 Principal Investigator.
Dr. Richard E. Fine provides a clinically insightful talk: “ICE3 Trial – Cryoablation of Low Risk Early Stage Breast Cancer – An Initial Overview”. The keynote presentation was given at the 20th World Conference of the International Society of Cryosurgery, 2019.
Prof. Ofer Nativ
Head of the Urological Department, Bnai Zion Medical Center, Israel.
Prof. Ofer Nativ shares his latest clinical update: “Increasingly RCC (Renal Cell Carcinoma) is diagnosed at an earlier stage and nephron-sparing surgery as well as ablative techniques are gaining more acceptance as the treatment of choice for small renal tumors.” The keynote presentation was given at the 20th World Conference of the International Society of Cryosurgery, 2019.
Prof. Eisuke Fukuma
Director of the Breast Center, Kameda Medical Center, Japan
Prof. Eisuke Fukuma shares his latest clinical findings in using the ProSense cryoablation system: “Nonsurgical Cryoablation for Small Breast Cancer – 12 Years Result.” The keynote presentation was given at the 20th World Conference of the International Society of Cryosurgery, 2019.
Dr. Youchi Machida,
Radiologist, Breast Center, Kameda Medical Center, Japan
Dr. Youchi Machida shares his recent findings on cryoablation of primary breast cancer without surgical resection “the patient was free of local recurrence for more than 3 years”. The keynote presentation was given at the 20th World Conference of the International Society of Cryosurgery, 2019.
Dr. Hiroaki Nomori
Chairman of the Department of General Thoracic Surgery, Kameda Medical Center, Japan
Dr Hiroaki Nomori covers his comparison of cryoablation for lung cancer using liquid nitrogen vs argon gas: “None of the tumors less than 1.8 cm experienced local recurrence”. The keynote presentation was given at the 20th World Conference of the International Society of Cryosurgery, 2019.
Dr. Sagi Shpritz
Resident Doctor, Urological Department, Bnai Zion Medical Center, Israel
Dr Sagi Shpritz shares his latest findings in using the ProSense cyroblation system: Cyroblation is the “Preferred approach for patients with multiple comorbidities or lesions that are technically complex for surgical treatment.” The keynote presentation was given at the 20th World Conference of the International Society of Cryosurgery, 2019.